Cargando…

Mutational analysis of reverse transcriptase and surface proteins of patients with partial virological response during mono and combination antiviral therapies in genotype D chronic hepatitis B

INTRODUCTION: The mutational pattern of chronic Hepatitis B virus (HBV) is unclear in patients who show incomplete response to antiviral therapy. The aims of this study were 1) to determine the benefit of combination therapy with adefovir dipivoxil (ADV) and Lamivudine (LAM) versus ADV or LAM alone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahabadi, Mostafa, Alavian, Seyed Moayed, Norouzi, Mehdi, Keyvani, Hossein, Mahmoudi, Mahmood, Jazayeri, Seyed Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Electronic physician 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965195/ https://www.ncbi.nlm.nih.gov/pubmed/27504160 http://dx.doi.org/10.19082/2466

Ejemplares similares

Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study
por: Kabir, Ali, et al.
Publicado: (2006)

Appropriate Genotyping of Hepatitis B Virus in Iran
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2015)

Distribution of Hepatitis C Virus Genotypes Among Azerbaijani Patients in Capital City of Iran-Tehran
por: Bokharaei-Salim, Farah, et al.
Publicado: (2013)

Distribution of Hepatitis C Virus Genotypes in Iranian Chronic Infected Patients
por: Jahanbakhsh Sefidi, Fatemeh, et al.
Publicado: (2013)

Drug-Related Mutational Patterns in Hepatitis B Virus (HBV) Reverse Transcriptase Proteins From Iranian Treatment-Naïve Chronic HBV Patients
por: Mahabadi, Mostafa, et al.
Publicado: (2013)

Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy
por: Daram, Maryam, et al.
Publicado: (2014)

High Rate of Virological Response to Peginterferon α-2a–Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C
por: Alavi Moghaddam, Mostafa, et al.
Publicado: (2012)

Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran
por: Alavian, Seyed Moayed
Publicado: (2015)

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
por: Dindoost, Payam, et al.
Publicado: (2012)

YMDD motif mutation after lamivudine therapy
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2011)

HCV genotypes distribution pattern in India
por: Bokharaei-Salim, Farah, et al.
Publicado: (2012)

Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis
por: Aalaei-Andabili, Seyed Hossein, et al.
Publicado: (2014)

Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study
por: Rezaee, Reza, et al.
Publicado: (2015)

Random effect model for identifying related factors to virological response in HCV patients
por: Zayeri, Farid, et al.
Publicado: (2013)

The Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients
por: Bokharaei-Salim, Farah, et al.
Publicado: (2016)

Occult Hepatitis B (OBH) in Clinical Settings
por: Alavian, Seyed Moayed, et al.
Publicado: (2012)

Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up
por: Sali, Shahnaz, et al.
Publicado: (2013)

HBV Vaccination Status and Response to Hepatitis B Vaccine Among Iranian Dentists, Correlation With Risk Factors and Preventive Measures
por: Momeni, Nafiseh, et al.
Publicado: (2014)

Sequencing and Phylogenetic Study of Partial NS3 Gene of Iranian GB Virus C/Hepatitis G Virus (HGV) Originated From Hemodialysis Patients in Tehran
por: Dadmanesh, Maryam, et al.
Publicado: (2015)

A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
por: Tasavon Gholamhoseini, Mohammad, et al.
Publicado: (2022)

IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report
por: Mahboobi, Nastaran, et al.
Publicado: (2011)

Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study
por: Poortahmasebi, Vahdat, et al.
Publicado: (2016)

Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

More Risk Factors of Hepatitis C Transmission Should be Considered in Pakistan
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis
por: Alavian, Seyed Moayed, et al.
Publicado: (2012)

Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features
por: Poortahmasebi, Vahdat, et al.
Publicado: (2015)

The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis
por: Ghaderi-Zefrehi, Hossein, et al.
Publicado: (2016)

Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1
por: Sharafi, Heidar, et al.
Publicado: (2015)

Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol
por: Jazayeri-Tehrani, Seyed Ali, et al.
Publicado: (2017)

Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
por: Jazayeri-Tehrani, Seyed Ali, et al.
Publicado: (2019)

Detection of Hepatitis B Virus Covalently Closed Circular DNA in the Plasma of Iranian HBeAg-Negative Patients With Chronic Hepatitis B
por: Tajik, Zahra, et al.
Publicado: (2015)

Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?
por: Khosravi, Mohammad Hossein, et al.
Publicado: (2016)

letter to Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic Analysis of Hepatitis C Virus in Khuzestan Province, Southwestern Iran. Middle East J Dig Dis 2011;3:126-30
por: Alavian, Seyed Moayed, et al.
Publicado: (2012)

HBV Subgenotypes D1, D2, D-del! Are ‘Old‘ Genotyping Methods Interpreted Correctly?
por: Amini-Bavil-Olyaee, Samad, et al.
Publicado: (2013)

Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial
por: Daneshi-Maskooni, Milad, et al.
Publicado: (2019)

Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial
por: Daneshi-Maskooni, Milad, et al.
Publicado: (2018)

The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial
por: Daneshi-Maskooni, Milad, et al.
Publicado: (2017)

Occult Hepatitis C Virus Infection in Candidates for Liver Transplant With Cryptogenic Cirrhosis
por: Keyvani, Hossein, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bshc1m45oa3oo0b1o7kiu1id00